Nephrosis, Lipoid - 25 Studies Found
Recruiting |
: Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease : Minimal Change Disease : 2009-09-21 :
|
Recruiting |
: Myfortic® for Minimal Change Nephrotic Syndrome (MCNS): a Randomized Study : Nephrosis, Lipoid : 2010-08-13 :
|
Completed |
: Therapeutic Effect of Tacrolimus in Combination With Low Dose Corticosteroid in Adult Patient With Minimal Change Nephritic Syndrome : Minimal Change Disease : 2010-03-10 : Drug: Tacrolimus tacrolimus 0.05mg/kg bid for 12 weeks corticosteroid 0.3 - 0.5mg/kg qd |
Completed |
: Latent Viral Infection of Lymphoid Cells in Idiopathic Nephrotic Syndrome : NEPHROSIS, LIPOID : 2007-12-19 |
Completed |
: The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy : IgA Nephropathy : 2011-10-07 : Drug: Prednisone or Prednisolone daily single dose of 1mg/kg (maximum 80mg) or alternate day single dose |
Completed |
: Rituximab in Multirelapsing Minimal Change Disease (MCD) or Focal Segmental Glomerulosclerosis (FSGS) : Nephrotic Syndrome : 2009-09-21 : Drug: Rituximab Rituximab (375 mg/m2) will be given as a single intravenous infusion after reconstitutio |
Not yet recruiting |
: Valproic Acid for Idiopathic Nephrotic Syndrome :
: Procedure: Kidney Biopsy Patients scheduled to undergo a clinically indicated kidney biopsy will be requ |
Completed |
: Retinoids for Minimal Change Disease and Focal Segmental Glomerulosclerosis :
: 2004-12-01 :
|
Recruiting |
: Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD) : Nephrotic Syndrome : 2015-10-29 :
|